Trump looks forward to such things, but he has made the situation quite complicated for the citizens of his country.

Trade groups are urging the administration to consider the impact on patient care and are pushing for exemptions to the tariffs. Also in the news: Pfizer might move production to the U.S. to combat ...

Pfizer reacts to Donald Trump’s tariff threats on big pharma, another regulatory meeting is canceled under RFK Jr., AbbVie ...

Jim Cramer remains optimistic about Pfizer’s CEO, Dr. Albert Bourla, despite the company’s struggles with debt and market volatility. Cramer highlighted how Pfizer is leveraging AI in its operations, ...

We recently compiled a list of the Jim Cramer Discusses These 11 Stocks & Shares ChatGPT’s Flaws. In this article, we are ...

Pfizer (PFE) may move overseas manufacturing to its existing plants in the U.S., if required, as the Trump administration threatens numerous ...

Eli Lilly also responded to the President's tariff warnings by investing $27 billion to construct four manufacturing ...

Europe’s pharmaceutical firms are rushing to prepare for the potential fallout of U.S. import duties, even as analysts warn ...

The burrito chain plans to “absorb” any additional costs that arise from tariffs on Canada and Mexico unless those costs turn into a “significant headwind,” CEO Scott Boatwright told NBC in an ...

"I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of President Donald Trump's ...

Big Pharma executives feel optimistic about their industry’s trajectory under a second Donald Trump presidency, with regulation rollbacks and other changes likely to boost bottom lines for drugmakers, ...

Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United ...